These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 10780527)

  • 1. Bisphosphonates induce apoptosis in human breast cancer cell lines.
    Senaratne SG; Pirianov G; Mansi JL; Arnett TR; Colston KW
    Br J Cancer; 2000 Apr; 82(8):1459-68. PubMed ID: 10780527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates induce breast cancer cell death in vitro.
    Fromigue O; Lagneaux L; Body JJ
    J Bone Miner Res; 2000 Nov; 15(11):2211-21. PubMed ID: 11092402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro toxicity of bisphosphonates on human neuroblastoma cell lines.
    Vorotnjak M; Boos J; Lanvers-Kaminsky C
    Anticancer Drugs; 2004 Sep; 15(8):795-802. PubMed ID: 15494642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.
    Shipman CM; Rogers MJ; Apperley JF; Russell RG; Croucher PI
    Br J Haematol; 1997 Sep; 98(3):665-72. PubMed ID: 9332325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro.
    Ziebart T; Pabst A; Klein MO; Kämmerer P; Gauss L; Brüllmann D; Al-Nawas B; Walter C
    Clin Oral Investig; 2011 Feb; 15(1):105-11. PubMed ID: 20024592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates.
    Aparicio A; Gardner A; Tu Y; Savage A; Berenson J; Lichtenstein A
    Leukemia; 1998 Feb; 12(2):220-9. PubMed ID: 9519785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
    Oades GM; Senaratne SG; Clarke IA; Kirby RS; Colston KW
    J Urol; 2003 Jul; 170(1):246-52. PubMed ID: 12796698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bisphosphonate zoledronic acid impairs Ras membrane [correction of impairs membrane] localisation and induces cytochrome c release in breast cancer cells.
    Senaratne SG; Mansi JL; Colston KW
    Br J Cancer; 2002 May; 86(9):1479-86. PubMed ID: 11986784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
    Pabst AM; Ziebart T; Koch FP; Taylor KY; Al-Nawas B; Walter C
    Clin Oral Investig; 2012 Feb; 16(1):87-93. PubMed ID: 21225298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates in breast cancer.
    Coleman RE
    Ann Oncol; 2005 May; 16(5):687-95. PubMed ID: 15802276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro.
    Sonnemann J; Eckervogt V; Truckenbrod B; Boos J; Winkelmann W; van Valen F
    Anticancer Drugs; 2001 Jun; 12(5):459-65. PubMed ID: 11395574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of genistein on molecular markers related to apoptosis in two phenotypically dissimilar breast cancer cell lines.
    Xu J; Loo G
    J Cell Biochem; 2001 Apr 2-27; 82(1):78-88. PubMed ID: 11400165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of bisphosphonates on breast cancer cell lines.
    Verdijk R; Franke HR; Wolbers F; Vermes I
    Cancer Lett; 2007 Feb; 246(1-2):308-12. PubMed ID: 16621245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro.
    Dalle Carbonare L; Valenti MT; Bertoldo F; Fracalossi A; Balducci E; Azzarello G; Vinante O; Lo Cascio V
    Aging Clin Exp Res; 2007 Apr; 19(2):91-6. PubMed ID: 17446718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic effect of clodronate and zoledronate on the chondrosarcoma cell lines HTB-94 and CAL-78.
    Streitbuerger A; Henrichs M; Ahrens H; Lanvers-Kaminzky C; Gouin F; Gosheger G; Hardes J
    Int Orthop; 2011 Sep; 35(9):1369-73. PubMed ID: 20890703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of bisphosphonates in breast and prostate cancers.
    Brown JE; Neville-Webbe H; Coleman RE
    Endocr Relat Cancer; 2004 Jun; 11(2):207-24. PubMed ID: 15163299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An audit to determine the time taken to administer intravenous bisphosphonate infusions in patients diagnosed with metastatic breast cancer to bone in a hospital setting.
    Barrett-Lee P; Bloomfield D; Dougherty L; Harries M; Laing R; Patel H; Walker M
    Curr Med Res Opin; 2007 Jul; 23(7):1575-82. PubMed ID: 17559749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines.
    Tassone P; Forciniti S; Galea E; Morrone G; Turco MC; Martinelli V; Tagliaferri P; Venuta S
    Leukemia; 2000 May; 14(5):841-4. PubMed ID: 10803515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.